Rx&D applauds decision upholding data protection

Guest Contributor
December 20, 2010

Canada's Research-Based Pharmaceutical Companies (Rx&D) are claiming victory following a Federal Court of Appeal ruling upholding a key clause in Canada's intellectual property regime. The ruling upholds a 2009 decision by the federal Court of Canada which dismissed a challenge by the generic drug industry to Food and Drug Regulations providing patent holders eight years of data protection. While applauding the decision for providing clarity and fairness, Rx&D stated that data protection must be extended "to match the standards set by our major trading partners"....


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.